Specially designed footwear reduces pain of knee osteoarthritis

knee
Credit: CC0 Public Domain

Wearing shoes specifically designed with a novel sole (biomechanical footwear) significantly reduces the pain associated with knee osteoarthritis.

Knee affects approximately 275 million people worldwide and in 2017 was estimated to account for 8.3 million years lived with disability. Acetaminophen, non-steroidal anti-inflammatory drugs and opioids are most commonly used drugs to treat pain but have limited effectiveness.

Researchers from Boston University School of Medicine (BUSM), the University of Toronto and the University of Bern Switzerland studied 220 participants who suffered with painful osteoarthritis. Half wore the biomechanical footwear while the others wore the "control" shoes. After six months of wearing the shoes, the biomechanical group had a larger decrease in their measured by the Western Ontario Osteoarthritis Index pain scale.

"These findings provide strong evidence supporting the effectiveness of a new treatment for ," said David Felson, MD, MPH, professor of medicine at BUSM and coauthor of the study. Felson, a rheumatologist at Boston Medical Center, believes the treatment probably works by re-educating and reconditioning muscles in the legs. "This treatment may help many persons with this disorder."

According to the researchers, not only does it appear to reduce pain in people with osteoarthritis, but may also be effective for some people with hip or back .

The authors caution that further research is needed to assess long-term efficacy and safety.

These findings appear online in JAMA.


Explore further

Knee pain sufferers can kick ugly shoes to the curb

Citation: Specially designed footwear reduces pain of knee osteoarthritis (2020, May 12) retrieved 1 June 2020 from https://medicalxpress.com/news/2020-05-specially-footwear-pain-knee-osteoarthritis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
23 shares

Feedback to editors

User comments